CD44 and osteosarcoma: This agrees with in vitro studies carried out in different osteosarcoma cell lines (KHOS doxorubicin resistant, U2-OS doxorubicin resistant, MNNG/HOS, and 143B) that demonstrated that CD44 promotes cell migration, cell invasiveness, and drug resistance (136, 137, 139, 170).